Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acute kidney failure (AKI) is one of the most important causes of morbidity and mortality for critical ill patients. The use of blood purification treatment such as renal replacement therapy (CRRT) and plasma exchange has gradually developed into an effective treatment. However, the efficiency of blood purification may be affected by the recirculation of dual-lumen venous catheter for some special patients including patients with vena cava reflux disorder from massive occupations or ascites. For extreme cases like patients with vena cava disconnection or severe obstruction, the traditional blood purification treatment cannot work effectively. Thus, we used the dual-cannula in jugular-femoral venous blood purification therapy in the following two patients and found that it can improve the perfusion of systemic circulation and the prognosis of patients
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| the treatment-as-usual group | No Intervention | we used the single-cannula in femoral venous blood purification therapy in the following patients with vena cava disconnection or severe obstruction | |
| intervention group | Experimental | we used the dual-cannula in jugular-femoral venous blood purification therapy in the following patients with vena cava disconnection or severe obstruction |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hemodialysis Catheter | Device | We add a dialysis catheter to the patient, i.e., replace single-cannula in femoral venous with dual-cannula in jugular-femoral venous |
|
| Measure | Description | Time Frame |
|---|---|---|
| vasoactive drugs | doses of vasoactive drugs | 144 hours after dual-cannula in jugular-femoral venous |
| ICU mortality | Measurement of ICU mortality | 28-day ICU mortality |
| Measure | Description | Time Frame |
|---|---|---|
| Cytokine | Checking cytokine levels by laboratory | 24hous after dual-cannula in jugular-femoral venous |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Zhunyong Gu | Contact | 8613918677995 | gu.zhunyong@zs-hospital.sh.cn |
| Name | Affiliation | Role |
|---|---|---|
| Minjie Ju, PHD | Shanghai Zhongshan Hospital | Study Director |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided